胶质瘤手术前后患者报告的认知功能
一项前瞻性人群研究纳入182例接受初次手术的弥漫性胶质瘤患者(141例高级别胶质瘤,41例低级别胶质瘤),术前及术后1、6个月采用EORTC QLQ-C30认知功能分量表评估患者报告的认知功能;高级别胶质瘤组平均认知功能评分从术前70.9(95%CI 66.6,75.2)升至术后1个月85.1(95%CI 81.2,89.0)(p<0.001)和术后6个月83.3(95%CI 79.1,87.6)(p<0.001),低级别胶质瘤组术前80.9(95%CI 74.4,87.4)并在术后随访中保持稳定;女性报告评分低于男性;术前使用皮质类固醇和大肿瘤体积是术后1个月认知改善的预测因素。
要点
- 高级别胶质瘤患者术后1个月和6个月患者报告的认知功能评分较术前升高(p<0.001)。
- 低级别胶质瘤患者术后认知功能评分保持稳定。
- 女性报告认知功能评分低于男性。
核心结论
- 许多胶质瘤患者在手术后经历围手术期主观认知功能变化。
- 在组水平上,高级别胶质瘤患者报告术后认知功能改善,而低级别胶质瘤患者报告认知功能稳定。
- 术前使用皮质类固醇和大肿瘤体积与术后改善独立相关。
研究设计与样本
- 前瞻性人群研究,纳入182例接受初次手术的弥漫性胶质瘤患者,其中高级别胶质瘤141例、低级别胶质瘤41例。
- 使用欧洲癌症研究与治疗组织(EORTC)QLQ-C30认知功能分量表在术前及术后1个月和6个月测量患者报告的认知功能。
- 采用二项逻辑回归模型评估可能与患者报告认知变化相关的因素。
主要发现
- 高级别胶质瘤组平均认知功能评分从术前70.9(95%CI 66.6,75.2)升至术后1个月85.1(95%CI 81.2,89.0)(p<0.001)和术后6个月83.3(95%CI 79.1,87.6)(p<0.001)。
- 低级别胶质瘤组平均评分术前为80.9(95%CI 74.4,87.4),在术后随访中保持稳定。
- 女性报告评分低于男性。
- 在个体水平上,低级别和高级别胶质瘤患者术后认知评分改善和恶化均常见。
- 术前使用皮质类固醇和大肿瘤体积是术后1个月认知改善的预测因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about the extent to which glioma patients experience subjective changes in cognitive function following surgery. We sought to assess patient-reported cognitive function before and after glioma surgery and explore potential factors associated with cognitive change. METHODS: In a prospective population-based study, patient-reported cognitive function was measured in 182 patients undergoing primary surgery for diffuse glioma (141 high-grade gliomas (HGG) and 41 low-grade gliomas (LGG)) by using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 cognitive function subscale preoperatively and at 1 and 6 months postoperatively. Binomial logistic regression models were used to assess factors possibly associated with patient-reported cognitive changes. RESULTS: In the HGG group, the mean cognitive function score increased from 70.9 (95% 66.6, 75.2) preoperatively to 85.1 (95% CI 81.2, 89.0) (p < 0.001) and 83.3 (95% CI 79.1, 87.6) (p < 0.001) at 1 and 6 months postoperatively, respectively. In the LGG group, the mean score was 80.9 (95% CI 74.4, 87.4) preoperatively and remained stable at postoperative follow-ups. Females reported lower scores than males. At an individual level, both improvement and deterioration in cognitive scores were frequently seen in LGG and HGG patients after surgery. Preoperative use of corticosteroids and large tumor volume were predictors for cognitive improvement at 1 month postoperatively. No predictors were identified for cognitive improvement at 6 months and worsening at 1 and 6 months. CONCLUSION: Many glioma patients experience perioperative subjective changes in cognitive function after surgery. At group level, HGG patients reported improved cognitive function after surgery, while LGG patients reported stable cognitive function. Preoperative use of corticosteroids and large tumor volume were independently associated with postoperative improvement.
引用
- Schei S, Solheim O, Salvesen Ø, et al. Patient-reported cognitive function before and after glioma surgery. Acta Neurochir (Wien). 2022. PMID: 35668303. doi:10.1007/s00701-022-05261-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。